“The 40-Gene Expression Profile Test Identifies Patients with National Comprehensive Cancer Network High-Risk Cutaneous Squamous Cell Carcinoma at High Risk of Poor Outcomes to Inform Management Decisions” (2025) SKIN The Journal of Cutaneous Medicine, 9(4), pp. 2426–2443. doi:10.25251/mvr2rn83.